WEBINAR – TUBERCULOSIS DIAGNOSTICS

On 6th March 2017, European AIDS Treatment Group and Treatment Action Group (TAG) have jointly organized the webinar on TB Diagnostics.

Moderator: Evgenia Maron

Speakers:

Ruth McNerney, University of Cape Town – TB Diagnostics
Erika Lessem, Treatment Action Group – Advocating for better TB diagnosis

Documents for the webinar

TUBERCULOSIS Diagnostics Technology

Tuberculosis Diagnostics in 2015: La

Tuberculosis Diagnostics in 2015: Landscape, Priorities, Needs, and Prospects

AN ACTIVIST’S GUIDE TO Tuberculosis

AN ACTIVIST’S GUIDE TO Tuberculosis Diagnostic Tools FEBRUARY

STARD checklist for the reporting of

STARD checklist for the reporting of studies of diagnostic accuracy. First official version, January 2003.

Slide set II - Towards Good Review P

Slide set II - Towards Good Review Practice: a training manual for the review of clinical performance of in vitro diagnostic medical devices

Review - New tuberculosis diagnostic

Review - New tuberculosis diagnostics and rollout - Ruth McNerney, Jane Cunningham, Pamela Hepple, Alimuddin Zumla

Improving access to new diagnostics

Improving access to new diagnostics through harmonised regulation: priorities for action Authors: Ruth

Impact of the Xpert MTB/RIF diagnost

Impact of the Xpert MTB/RIF diagnostic test for tuberculosis in countries with a high burden of disease

Emerging technologies in point-of-ca

Emerging technologies in point-of-care molecular diagnostics for resourcelimited settings

Evaluation of diagnostic tests for i

Evaluation of diagnostic tests for infectious diseases: general principles

International Journal of Infectious

International Journal of Infectious Diseases

Diagnostics for Developing Countries

Increasing Access to Diagnostics Thr

Increasing Access to Diagnostics Through Technology Transfer and Local Production

WEBINAR – TUBERCULOSIS TREATMENT

On 13th March 2017, European AIDS Treatment Group and Treatment Action Group (TAG) have jointly organized the webinar on TB Treatment.

Moderator: Evgenia Maron, EATG TB Portfolio Coordinator

Speakers:

Jennifer Hughes, Médecins Sans Frontières (MSF):
Experience of treating multi-drug-resistant and extensively drug-resistant TB and using the new drugs
Erica Lessem, Treatment Action Group:
Advocating for improved multi-drug-resistant TB treatment

The European AIDS Treatment Group (EATG)

Médecins Sans Frontières (MSF) International

Speakers Bio

Jennifer Hughes

Dr Jenny Hughes, a TB doctor in South Africa working with Doctors Without Borders (MSF), graduated from Cardiff University in Wales in 2005. A few years later, she moved to South Africa to gain experience in a different healthcare setting. Witnessing first-hand the devastating effects of TB on impoverished communities is what ignited her passion to treat patients suffering from this curable but largely neglected disease. Since 2010 she has worked in Khayelitsha, Western Cape, where MSF runs a strengthened regimen programme for drug-resistant TB patients that incorporates new drugs into their treatment.

Erica Lessem

As Director of theTB/HIV Project at Treatment Action Group (TAG), Erica Lessem advocates for improved services and technologies to prevent, diagnose, and treat TB and HIV. In this role, Erica supports research activists across the world, and works closely with developers and policymakers to catalyze TB research and ensure that it responds to the needs of affected communities. Previously, Erica worked on HIV behavioral research studies, supported efforts to end sex trafficking in South Asia, volunteered for the Baltimore CityNeedle Exchange Program, was a grant writer for the TB Alliance, conducted press relations as an Urban Fellow in the New York City Department of Health and Mental Hygiene, and helped create the Republic of Georgia’s first peer support group for breast cancer survivors. Erica received Bachelor of Arts in Spanish and Psychology from Georgetown University, and her Master of Public Health as a Sommer Scholar at the Johns Hopkins Bloomberg School of Public health.